Breaking News Instant updates and real-time market news.

RETA

Reata Pharmaceuticals

$208.94

2.86 (1.39%)

06:45
11/04/19
11/04
06:45
11/04/19
06:45

Reata Pharmaceuticals price target raised to $250 from $180 at Cantor Fitzgerald

Cantor Fitzgerald analyst Charles Duncan raised his price target for Reata Pharmaceuticals to $250 from $180 and keeps an Overweight rating on the shares. The analyst says results from his recent key opinion leader due diligence enhances his conviction in the clinical value for bardoxolone's Phase 3 Cardinal study in Alport syndrome.

RETA Reata Pharmaceuticals
$208.94

2.86 (1.39%)

10/15/19
BARD
10/15/19
NO CHANGE
Target $162
BARD
Outperform
Reata Pharmaceuticals price target raised to $162 from $105 at Baird
Baird analyst Brian Skorney raised his price target to $162 from $105 following news its omaveloxolone hit the primary endpoint in MOXle, a place controlled study in Friedreich's ataxia. The study was a major surprise and may now push towards blockbuster status. Skorney reiterated his Outperform rating on Reata Pharmaceuticals shares.
10/15/19
JEFF
10/15/19
NO CHANGE
Target $254
JEFF
Buy
Reata Pharmaceuticals price target raised to $254 from $128 at Jefferies
Jefferies analyst Maury Raycroft raised his price target for Reata Pharmaceuticals to $254 from $128 and and maintained a Buy rating, telling investors in a research note that the company's to-line data from the registrational Part 2 portion of the MOXIe Phase 2 trial of omaveloxolone in patients with Friedreich's ataxia seem "impressive" on the primary endpoint, and believes the unmet need and totality of data will be enough to get the drug approved. Raycroft says the positive FA results were "unexpected."
10/16/19
STFL
10/16/19
NO CHANGE
Target $210
STFL
Buy
Reata Pharmaceuticals price target raised to $210 from $135 at Stifel
Stifel analyst Adam Walsh increased his price target on Reata Pharmaceuticals to $210 from $135 after omaveloxolone in patients with Friedreich's ataxia hit the "FDA-blessed" primary endpoint of placebo-corrected mFARS in the MOXIe trial. He, and his key-opinion leader consultant, think omaveloxolone first-pass approval is likely based on the trial results reported, especially given the "benign" safety and tolerability, Walsh tells investors. Beyond omaveloxolone, he remains bullish ahead of Alport data due out this quarter, Walsh added.
10/16/19
LTCO
10/16/19
NO CHANGE
Target $239
LTCO
Buy
Reata Pharmaceuticals price target raised to $239 from $133 at Ladenburg
Ladenburg Thalmann analyst Matthew Kaplan raised his price target for Reata Pharmaceuticals to $239 from $133 after the company announced positive topline data from Part 2 of the MOXIe registrational trial of omaveloxolone in patients with Friedreich's ataxia. Importantly, omaveloxolone treatment not only halted the progression of the disease but actually showed improvement in the largest Friedreich's trial to date, Kaplan tells investors in a research note. He believes the data are sufficient as a registrational study for approval of omaveloxolone in Friedreich's Ataxia. The analyst reiterates a Buy rating on Reata Pharmaceuticals and says his new price target reflects to the increased probability of approval of omaveloxolone in Friedreich's ataxia.

TODAY'S FREE FLY STORIES

BECN

Beacon Roofing

$28.96

-0.13 (-0.45%)

08:43
12/10/19
12/10
08:43
12/10/19
08:43
Conference/Events
Beacon Roofing management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

  • 19

    Dec

DY

Dycom

$46.37

-4.565 (-8.96%)

08:42
12/10/19
12/10
08:42
12/10/19
08:42
Recommendations
Dycom analyst commentary  »

Dycom selloff after note…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

THO

Thor Industries

$64.28

-3.485 (-5.14%)

08:41
12/10/19
12/10
08:41
12/10/19
08:41
Recommendations
Thor Industries analyst commentary  »

Thor Industries price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NWE

NorthWestern

$71.27

-0.57 (-0.79%)

08:41
12/10/19
12/10
08:41
12/10/19
08:41
Earnings
NorthWestern backs FY19 adjusted EPS view $3.38-$3.48, consensus $3.42 »

Sees FY20 adjusted EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SPY

SPDR S&P 500 ETF Trust

$313.89

-0.93 (-0.30%)

, SPX

S&P 500

$0.00

(0.00%)

08:40
12/10/19
12/10
08:40
12/10/19
08:40
Periodicals
U.S. and China negotiators planning for delay of Dec. 15 tariffs, WSJ says »

U.S. and Chinese trade…

SPY

SPDR S&P 500 ETF Trust

$313.89

-0.93 (-0.30%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:40
12/10/19
12/10
08:40
12/10/19
08:40
General news
Breaking General news story  »

Week of 12/7 Redbook to…

08:40
12/10/19
12/10
08:40
12/10/19
08:40
General news
Breaking General news story  »

Week of 12/7 Redbook to…

ALMFF

Altium

$0.00

(0.00%)

08:39
12/10/19
12/10
08:39
12/10/19
08:39
Initiation
Altium initiated  »

Altium initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$42.37

0.22 (0.52%)

08:38
12/10/19
12/10
08:38
12/10/19
08:38
Hot Stocks
Breaking Hot Stocks news story on Aecom »

Aecom sees FY21 adj.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

BCOV

Brightcove

$9.21

-0.11 (-1.18%)

08:38
12/10/19
12/10
08:38
12/10/19
08:38
Conference/Events
Brightcove management to meet with Northland »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ACM

Aecom

$42.37

0.22 (0.52%)

08:38
12/10/19
12/10
08:38
12/10/19
08:38
Hot Stocks
Breaking Hot Stocks news story on Aecom »

Aecom backs FY20 adj.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AMCX

AMC Networks

$38.02

-0.18 (-0.47%)

08:37
12/10/19
12/10
08:37
12/10/19
08:37
Hot Stocks
AMC Networks says four targeted SVOD services exceed 2M subscribers »

AMC Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GCAP

Gain Capital

$4.12

0.165 (4.17%)

08:37
12/10/19
12/10
08:37
12/10/19
08:37
Hot Stocks
GAIN Capital reports November operating metrics »

In the retail segment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBTS

Powerbridge

$3.05

0.09 (3.04%)

08:37
12/10/19
12/10
08:37
12/10/19
08:37
Earnings
Powerbridge awarded contract for Hefei Integrated Special Regulated Zone »

Powerbridge Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$313.89

-0.93 (-0.30%)

, SPX

S&P 500

$0.00

(0.00%)

08:36
12/10/19
12/10
08:36
12/10/19
08:36
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

U.S., China negotiators…

SPY

SPDR S&P 500 ETF Trust

$313.89

-0.93 (-0.30%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTN

Vail Resorts

$231.30

-1.43 (-0.61%)

08:35
12/10/19
12/10
08:35
12/10/19
08:35
Recommendations
Vail Resorts analyst commentary  »

Vail Resorts price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBW

Build-A-Bear

$2.90

-0.1 (-3.33%)

08:35
12/10/19
12/10
08:35
12/10/19
08:35
Conference/Events
Build-A-Bear management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

08:35
12/10/19
12/10
08:35
12/10/19
08:35
General news
U.S. NFIB small business optimism index climbed 2.2% to 104.7 in November »

U.S. NFIB small business…

EMN

Eastman Chemical

$77.40

-0.1 (-0.13%)

08:34
12/10/19
12/10
08:34
12/10/19
08:34
Hot Stocks
Eastman Chemical CFO Curtis Espeland to retire, William McLain to succeed »

Eastman Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWE

NorthWestern

$71.27

-0.57 (-0.79%)

08:34
12/10/19
12/10
08:34
12/10/19
08:34
Hot Stocks
NorthWestern to acquire 25% share of Colstrip Unit 4 from Puget Sound Energy »

NorthWestern Energy will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

08:34
12/10/19
12/10
08:34
12/10/19
08:34
Recommendations
Stitch Fix analyst commentary  »

Stitch Fix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 19

    Dec

UGP

Ultrapar

$5.17

-0.03 (-0.58%)

08:33
12/10/19
12/10
08:33
12/10/19
08:33
Upgrade
Ultrapar rating change  »

Ultrapar upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$37.11

0.005 (0.01%)

08:33
12/10/19
12/10
08:33
12/10/19
08:33
Hot Stocks
BP and Arzeda enter into second extended collaboration agreement »

BP and Arzeda, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AVD

American Vanguard

$16.44

0.12 (0.74%)

08:33
12/10/19
12/10
08:33
12/10/19
08:33
Conference/Events
American Vanguard management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

DERM

Dermira

$9.09

1.2 (15.21%)

08:32
12/10/19
12/10
08:32
12/10/19
08:32
Hot Stocks
Dermira receives FDA Fast Track designation for lebrikizumab »

Dermira announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.